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National and international registries are essential tools for establishing new standards and comparing success
rates, but they do not take into account the total pregnancy/delivery rate per oocyte recovery. In Switzerland and
Germany, because of legal constraints, a maximum of three two-pronuclear zygotes are allocated for transfer
whereas all the supernumerary pronuclear zygotes are immediately cryopreserved, preventing selection of the
transferred embryos. We report on a 10 years’ experience (1993–2002) of our centre which performs transfers of
unselected embryos and cryopreservation at the two-pronuclear zygote stage. As ,30% of all deliveries are from
cryo cycles, it is essential to take into account the contribution of the cryo transfers, and we propose therefore to
evaluate, as a measure of IVF performance, the cumulated delivery rate per oocyte pick-up. This delivery rate is
broken down further into the cumulated singleton delivery rate (CUSIDERA) and the cumulated twin delivery
rate (CUTWIDERA). The sum (S) of these two rates is a measure of efficacy while the ratio CUTWIDERA/S as a
percentage is a measure of safety of IVF treatments. Using these new indexes, the average 10 year efficacy and
safety of our IVF programme were 26 and 19%, respectively. Both CUSIDERA and CUTWIDERA can be calcu-
lated easily in any clinical situation and yield useful parameters for patient counselling and internal/external
benchmarking purposes.
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Introduction
The outcome measure of an IVF treatment has been critically
reviewed in several recent issues of this journal (Davies et al.,
2004; Dickey et al., 2004; Griesinger et al., 2004; Land and
Evers, 2004; Min et al., 2004). The debate has focused not
only on the clinical performance in terms of pregnancy or
delivery rates per any type of denominator, but also on other
associated risks and complications, such as multiple births or
other maternal risks. The safest approach to assisted repro-
duction has been proposed to be ‘Children for infertile
couples, but one at a time’ (Adashi et al., 2003). Reducing
the number of transferred embryos from three to two has
been shown in several studies to reduce the multiple ges-
tation rates without affecting the pregnancy rate per transfer
(Staessen et al., 1995; Templeton and Morris, 1998). Along
the same line of thought, the transfer of a single embryo has
become a legal obligation in some countries with the objec-
tive of reducing the twin pregnancy rate (Gerris et al., 2002;
Adashi et al., 2003). Elective single embryo transfer (eSET)
is, however, technically dependent on an in vitro selection of
the most suitable embryo (Martikainen et al., 2004), which is
impossible to apply in some countries for legal reasons.
In Switzerland and Germany, the law restricts to three the
number of embryos that may be kept in culture beyond
the two-pronuclear (2PN) zygote stage (Germond and Senn,
1999; van der Ven et al., 2002). Furthermore, as cryopreser-
vation of the second or third best cleavage stage embryo is
forbidden, the transfer of a single embryo would imply the
destruction of the non-transferred ones. eSET is thus in our
context legally and ethically inapplicable. The remaining
choices are to keep only two zygotes in culture and cryopre-
serve all supernumerary 2PN zygotes. The consequences of
this attitude are a lower pregnancy rate per transfer compared
with that obtained after the transfer of selected embryos and
the necessity to establish a high standard cyropreservation
programme at the 2PN zygote stage.
Cryopreservation has to be considered in evaluating
IVF outcome
Most centres evaluate their IVF performance by measuring
pregnancies or deliveries following fresh embryo transfers
without including cryo transfers. Cumulating fresh and cryo
transfers has been presented recently as a critical issue to
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evaluate outcome of IVF treatments (Davies et al., 2004;
Pinborg et al., 2004). In the Swiss and German context, it is
essential to take into account the contribution of the cryo
transfers, and we propose therefore to evaluate, as a measure
of IVF performance, the cumulated delivery rates per oocyte
pick-up (OPU). This measure can be broken down further
into the cumulated singleton delivery rate (CUSIDERA) and
the cumulated twin delivery rate (CUTWIDERA), as shown
in Figure 1.
When only fresh transfers were considered, the singleton
delivery rate per OPU obtained in our centre reached 13.1%,
which was similar to the birth emphasizing successful
singleton at term (BESST, 11.1%) reported by Min et al.
(2004). However, when the corresponding frozen transfers
were included, the CUSIDERA increased to 21.7%. The
CUSIDERA increased over the years and has reached values
close to 25% since 1998. The lower rate observed for the year
2002 is due to the fact that most zygotes frozen in 2002 have
not been thawed and transferred yet. When calculated accord-
ing to age at the time of OPU, both CUSIDERA and CUTWI-
DERA decreased with age (,35 years: 26.6 and 6.2%, 35–39
years: 19.9 and 5.0%, .39 years: 9.3 and 1.5%).
Policies concerning selection and cryopreservation of
human embryos vary among different countries, mainly due
to specific local ethical considerations and legal constraints.
One of the main advantages of CUSIDERA and CUTWI-
DERA is that they may be used to evaluate outcomes inde-
pendently of the freezing policy and the cleavage stage of the
embryos at freezing. This may allow the strategy resulting in
the best outcome to be determined. The benefits of freezing
zygotes instead of embryos were already demonstrated (Senn
et al., 2000), but a recent report on the improvement of blas-
tocyst freezing (Gardner et al., 2003) is also promising.
CUTWIDERA and CUSIDERA as a measure of safety
and efficacy
The sum of CUSIDERA and CUTWIDERA may be used
as a measure of efficacy, and the ratio of CUTWI-
DERA/(CUSIDERA þ CUTWIDERA) £ 100 may be con-
sidered as a measure of safety. This safety ratio is 19%
[(5/(21 þ 5)) £ 100] in our centre. In order to approach the
natural twin conception of 1–2% (Antoine et al., 2004), the
CUTWIDERA should be lowered to at least 1%, but this
should be achieved without affecting the CUSIDERA.
Land and Evers (2004) compared efficacy (delivery rate
per OPU) related to safety (number of embryos per transfer)
between different countries. In their study, Switzerland, when
only fresh transfers were included, presented a low efficacy
(,20% delivery rate per OPU) combined with a high safety
(#2 embryos per transfer). By determining efficacy with the
CUSIDERA and CUTWIDERA, Switzerland would have
appeared in the quadrant which combines both maximum
efficacy and safety (26% efficacy with two transferred
embryos), despite the lack of embryo selection. In our
opinion, this increase in efficacy is due to the use of the
2PN zygote freezing policy, which maximizes the recovery
of intact zygotes after thawing and minimizes the number of
discarded embryos.
Twin deliveries should be reduced
Triplet pregnancies can be nearly eliminated by limiting the
number of transferred embryos to two. Reducing the number
of twin pregnancies is still a matter of debate, as the birth of
twins may appear acceptable for a number of patients and
clinicians (Dickey et al., 2004). However, twin pregnancies
are more likely to be responsible for premature birth and
growth retardation than single pregnancies, resulting in a
costly medical follow-up during gestation, the perinatal
period and childhood (Adashi et al., 2003). In addition, the
economic and psychological difficulties of parents after the
birth of twins cannot be denied. To reduce twin pregnancies,
the transfer of a single embryo is the only efficient policy.
However, in order to avoid a drop in the outcome, eSET
implies an accurate selection of the best embryo, combined
with great expertise in clinical and laboratory work (Gerris
et al., 2002).
Under the pressure of neonatologists, the Swiss Reproduc-
tive Medicine Society has strongly encouraged centres since
1998 to reduce the number of transferred embryos to two.
This change has not compromised the pregnancy outcome in
our centre and had little impact on the CUTWIDERA, which
remained close to 5% over the last 10 years. As a conse-
quence, to reach a 1% CUTWIDERA, better selection tools
at the patient, zygote and oocyte levels need to be developed.
Conclusion
The combined use of CUSIDERA and CUTWIDERA should
satisfy quality assurance by allowing a standardized
evaluation of both efficacy and safety and by offering a
benchmarking tool for internal/external audits. CUSIDERA
Figure 1. Cumulated singleton and twin delivery rates according to
the year of OPU. The cumulated rates were calculated as the num-
ber of deliveries resulting from fresh and cryo transfers per OPU.
Stimulated IVF/ICSI cycles (n ¼ 4122) performed in our centre
from January 1993 to December 2002 were extracted from the
Swiss national FIVNAT-CH registry. Up to three 2PN zygotes were
allocated for fresh transfer, while all supernumerary zygotes were
immediately frozen using a slow freezing technique. Each frozen
straw contained one or two zygotes in order to thaw the exact num-
ber of zygotes which had been determined previously during patient
counselling. Thawed zygotes were cultivated for 24 h before the
transfer, to allow for the first cleavages to occur.
Cumulated singleton and twin delivery rates
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and CUTWIDERA may be calculated in all clinical situations
and allow counselling of patients more specifically and com-
parison of centres or countries in terms of efficacy/safety.
Finally, this measure may also prove to be the most relevant
standard of success when ethical and legal arguments or
public health costs are considered.
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